Loading...
Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma
Although targeted therapy can prolong the survival of non-small cell lung cancer (NSCLC) patients with EGFR mutations, chemotherapy still is the choice for patients with wild-type EGFR or failure in targeted therapy. However, most of the patients will eventually develop chemoresistance. Our previous...
Na minha lista:
| Udgivet i: | Am J Cancer Res |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
e-Century Publishing Corporation
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4937735/ https://ncbi.nlm.nih.gov/pubmed/27429846 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|